NO157736C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.

Info

Publication number
NO157736C
NO157736C NO821206A NO821206A NO157736C NO 157736 C NO157736 C NO 157736C NO 821206 A NO821206 A NO 821206A NO 821206 A NO821206 A NO 821206A NO 157736 C NO157736 C NO 157736C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically effective
analogy procedure
imidazold
derivatives
Prior art date
Application number
NO821206A
Other languages
English (en)
Norwegian (no)
Other versions
NO157736B (no
NO821206L (no
Inventor
Peter John Fellner
Mun Fook Lai
Thakorbhai Parshotambhai Patel
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of NO821206L publication Critical patent/NO821206L/no
Publication of NO157736B publication Critical patent/NO157736B/no
Publication of NO157736C publication Critical patent/NO157736C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO821206A 1981-04-13 1982-04-13 Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater. NO157736C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8111614 1981-04-13

Publications (3)

Publication Number Publication Date
NO821206L NO821206L (no) 1982-10-14
NO157736B NO157736B (no) 1988-02-01
NO157736C true NO157736C (no) 1988-05-11

Family

ID=10521121

Family Applications (1)

Application Number Title Priority Date Filing Date
NO821206A NO157736C (no) 1981-04-13 1982-04-13 Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.

Country Status (12)

Country Link
US (2) US4567189A (de)
EP (1) EP0062918B1 (de)
JP (1) JPS57179165A (de)
CA (1) CA1174680A (de)
DE (1) DE3272262D1 (de)
DK (1) DK162882A (de)
ES (1) ES8304091A1 (de)
IE (1) IE52702B1 (de)
NO (1) NO157736C (de)
NZ (1) NZ200300A (de)
PT (1) PT74736B (de)
ZA (1) ZA822478B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0105575B1 (de) * 1982-07-12 1987-03-04 G.D. Searle & Co. 1-(1H-Imidazolyl), 1-N-Morpholinyl- und Pyridyl-Verbindungen, ihre Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
FR2557875B1 (fr) * 1984-01-11 1986-04-25 Jouveinal Sa Aminoethylimidazole, composition pharmaceutique en contenant et procede de preparation
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc
US5214063A (en) * 1990-06-27 1993-05-25 Adir Et Compagnie 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors
GB9127304D0 (en) * 1991-12-23 1992-02-19 Boots Co Plc Therapeutic agents
GB9312893D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
US5747523A (en) * 1996-01-24 1998-05-05 Guilford Pharmaceuticals Inc. Substituted ethyl α,α-diarylmethyl ether derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036970A (en) * 1975-07-28 1977-07-19 Syntex (U.S.A.) Inc. Imidazol-1-yl propane derivatives
DE2720949A1 (de) * 1977-05-10 1978-11-23 Bayer Ag Azolylaether-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide
US4215220A (en) * 1978-09-11 1980-07-29 Cilag-Chemie A.G. 1-(2-Oxysubstituted-3-anilinopropyl)-imidazoles
DK157860C (da) * 1979-06-07 1990-07-30 Shionogi & Co Analogifremgangsmaade til fremstilling af benzylimidazolderivater samt farmaceutisk acceptable syreadditionssalte deraf

Also Published As

Publication number Publication date
US4567189A (en) 1986-01-28
ZA822478B (en) 1983-02-23
NO157736B (no) 1988-02-01
PT74736B (en) 1983-11-09
IE52702B1 (en) 1988-01-20
EP0062918A2 (de) 1982-10-20
CA1174680A (en) 1984-09-18
NZ200300A (en) 1985-05-31
IE820868L (en) 1982-10-13
ES511317A0 (es) 1983-02-16
EP0062918A3 (en) 1983-09-28
DK162882A (da) 1982-10-14
ES8304091A1 (es) 1983-02-16
JPH0368864B2 (de) 1991-10-30
NO821206L (no) 1982-10-14
US4636518A (en) 1987-01-13
JPS57179165A (en) 1982-11-04
EP0062918B1 (de) 1986-07-30
PT74736A (en) 1982-05-01
DE3272262D1 (en) 1986-09-04

Similar Documents

Publication Publication Date Title
NO163691C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider.
NO821087L (no) Fremgangsmaate for fremstilling av cyklobutan-derivater.
NO158461C (no) Analogifremgangsmaate for fremstilling av fenyl-piperidin-propanol-derivater.
NO161372C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive guaninderivater.
NO162022C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater.
NO159446C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO152904C (no) Analogifremgangsmaate til fremstilling av farmakologisk virksomme heksapyranoseforbindelser.
NO167569C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO159930C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO820959L (no) Fremgangsmaate til fremstilling av acyl-kinolinonderivater
NO821904L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive kinolinderivater.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO155693C (no) Fremgangsmaate for fremstilling av eburnamoninderivater.
NO822634L (no) Fremgangsmaate for fremstilling av cefemderivater.
NO156865C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO151196C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme fluorerte alkenylendiaminderivater
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO158376C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme rooperolforbindelser.
NO158063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolo-pyrido-diazepin-derivater.
NO157736C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO155539C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme isokinolinderivater.
NO822119L (no) Fremgangsmaate for fremstilling av farmakologisk aktive benztriazol-derivater.
NO154965C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolderivater.
NO159268C (no) Fremgangsmaate for fremstilling av 3-pikolin.